Gabrail Cancer & Research Center
Skip to content
  • For Patients
    • New Patients
      • Request An Appointment
      • Referrals
    • What to expect?
      • Symptom Management
    • Patient Testimonials
    • Satisfaction Survey
  • Our Services
    • Clinical Trials
      • Clinical Research Trials (CRT)
    • Infusion Therapy
    • Instant Imaging
    • On Site Lab Services
    • The Liberty Pharmacy
    • Family Cancer Registry
    • Community Outreach
  • Clinical Trials
    • Clinical Trials at GCC
    • About Clinical Trials
      • Clinical Trial Phases
    • For Sponsors
      • Sponsor Testimonials
    • Approved Oncology Drugs
  • About Us
    • Physicians
    • Our Staff
    • Mission Statement
    • Location
    • Careers
  • Media
    • Podcasts
      • The Cancer Gene
      • Good Medicine Is Cheaper Medicine
    • Radio
    • TV
    • Articles
August 15, 2016 gabrailcancercenter

Multiple Myeloma

The Gabrail Cancer Center currently has many Clinical Trial opportunities . For more information and to see if you qualify call Carrie Smith R.N., Director of Research at 330-492-3345 x 208 or email CSmith@GabrailCancerCenter.com.

A Phase 1/2 Open-label Study to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Modakafusp Alfa (TAK-573) as a Single Agent in Patients With Relapsed Refractory Multiple Myeloma

A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of Intravenous Modakafusp Alfa as Part of Combination Therapy in Adult Patients With Multiple Myeloma

Return to Clinical Trials at GCC

Subscribe to Podcast

4875 Higbee Ave NW Canton, OH 44718
cantondesk@gabrailcancercenter.com
330-492-3345
  • Facebook link
  • Instagram link
Zerif Lite developed by ThemeIsle
This website uses cookies to improve your experience. We'll assume you accept this policy as long as you are using this websiteAcceptView Policy